Products for Research Use Only
RegisterLogin

NSC 107512

CAT: 0804-HY-141687-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-141687-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
NSC 107512 is a potent inhibitor of cyclin-dependent kinase 9 (CDK9) . NSC 107512 is a class of sangivamycin-like molecules (SLM) . NSC 107512 inhibits growth and induces apoptosis of multiple myeloma tumors[1].
CAS Number
22242-89-3
UNSPSC
12352005
Target
Apoptosis; CDK
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nsc-107512.html
Purity
99.97
Solubility
DMSO : 170 mg/mL (ultrasonic)
Smiles
O[C@H]1[C@](O[C@@H]([C@H]1O)CO)([H])N2C3=NC=NC(N)=C3C(C(NO)=N)=C2
Molecular Formula
C12H16N6O5
Molecular Weight
324.29
References & Citations
[1]Dolloff NG, et al. Sangivamycin-like molecule 6 exhibits potent anti-multiple myeloma activity through inhibition of cyclin-dependent kinase-9. Mol Cancer Ther. 2012;11 (11) :2321-2330.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-171152NSC 357754
HY-105293NSC 727357
HY-22159-01NSC 409012
HY-160638-01NSC-311068
HY-152168-01NSC 295642
HY-119172-01NSC-60339
HY-15480-01NSC 42834
HY-B1714A-01NSC 601980
HY-Y0057-01NSC 13138
HY-164402NSC-124854

Alternative Products

CatalogName
T60884-01NSC 107512

Popular Products